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Edited by Masayuki MiyasakaAbstract CpG oligodeoxunucleotide (ODN) plays an impor-
tant role in immune cell function. The present study examined
whether temporal control of toll-like receptor (TLR)-9 by CpG
ODN can regulate the expression of matrix metalloproteinase-
9 (MMP-9). CpG ODN induced the release of tumor necrosis
factor (TNF)-a and the expression of TNF receptor (TNFR)-
II, but not of TNFR-I, in a time-dependent manner and stimu-
lated signiﬁcant, though delayed, MMP-9 expression. The
endosomal acidiﬁcation inhibitors, chloroquine or baﬁlomycin
A, inhibited CpG ODN-induced TNF-a, TNFR-II, and MMP-
9 expression. CpG ODN induced the phosphorylation of Akt,
and the inhibition of Akt by LY294002 suppressed CpG ODN-
induced TNF-a, TNFR-II, and MMP-9 expressions. Moreover,
neutralizing TNF-a antibody signiﬁcantly suppressed CpG
ODN-induced MMP-9 expression, suggesting the involvement
of TNF-a. These observations suggest that CpG ODN may play
important roles in macrophage activation by regulating the
expression of MMP-9 via a TLR-9/Akt/TNF-a-dependent sig-
naling pathway.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Cells of the innate immune system respond to pathogens by
recognizing conserved pathogen-associated molecular patterns
[1]. Pathogen-associated molecular patterns include lipopoly-
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doi:10.1016/j.febslet.2006.06.100DNA. Bacterial DNA induces interferon-c production and
activates NK cells, and B-cell and macrophages are subse-
quently identiﬁed as direct cellular targets of bacterial DNA
[2–4]. The immunostimulatory activity of bacterial DNA re-
quires an unmethylated CG dinucleotide within a certain base
context (CpG motif). CpG oligodeoxynucleotide (ODN), a
synthetic analog of bacterial DNA, is capable of activating in-
nate immunity, including macrophages, and the recognition of
CpG requires the expression of intracellular toll-like receptor
(TLR)-9, which is constitutively expressed by macrophages
[4–6]. Upon internalization, CpG binds to TLR-9 in early
endosomes and triggers a signaling cascade mediated via
MyD88 and NF-jB. Consequently, CpG-stimulated macro-
phages secrete tumor necrosis factor (TNF)-a and various
cytokines as well as other factors involved in immune reactions
[7,8].
TNF-a is the predominant cytokine during early response to
acute extracellular infection and is an important mediator of
inﬂammatory immune responses. There are two major cell sur-
face receptors for TNF-a, type I TNF receptor (TNFR) and
type II TNFR, both of which belong to the TNFR superfamily
and bind TNF-a with high aﬃnity [9,10]. Although binding of
activated TNF-a to its receptors can result in the activation of
signaling events, signaling triggered by TNFR-I and TNFR-II
usually cause the activation of transcription factors, which
then induce numerous genes, such as matrix metalloproteinase
(MMP)-9, that are involved in inﬂammatory responses [11,12].
TNF-a-induced MMP-9 is associated with invasion. TNF-a is
one of the key mediators of MMP-9 induction, because mod-
ulation of autocrine TNF-a directly stimulates MMP-9 expres-
sion [13,14], or TNF-a neutralizing antibodies or the inhibition
of TNF-a-induced MMP activity by MMP inhibitors are eﬀec-
tive in the treatment of rheumatoid arthritis [15]. However,
although the roles of MMP in inﬂammatory cell functions
have been examined, the predominant focus of attention has
been the eﬀect of MMPs on adhesion and migration. In addi-
tion, although many studies have emphasized the role of CpG
ODN as a strong immunomodulator, no information is
available regarding to its potential contribution to MMP-9
expression.
In this study, we investigated whether CpG ODN induces
the phosphorylation of Akt in murine macrophage Raw264.7
cells, and whether Akt signaling events mediate the expressions
of TNF-a, TNFR-II, and MMP-9.blished by Elsevier B.V. All rights reserved.
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2.1. Reagents and antibodies
Cell culture reagents, including FBS, were obtained from Life Tech-
nologies (Grand Island, NY), CpG ODN, gelatin, and chloroquine
were from Sigma–Aldrich Co. (St. Louis, MO), TNF-a ELISA kits
were from R&D Systems (Minneapolis, MN), polyclonal MMP-9 anti-
body from Cayman Chemical (Ann Arbor, MI), TNFR-I and -II anti-
bodies from Santa-Cruz Biotechnology (Santa-Cruz, CA), and Akt and
phospho-Akt antibodies from Cell Signaling (Beverly, MA). LY294002
and baﬁlomycin A were purchased from Calbiochem (San Diego, CA).
2.2. Cell culture
Murine macrophages, Raw264.7 cells (ATCC, CCL-2278), were
grown in RPMI 1640 supplemented with heat-inactivated 10% FBS,
2 mM L-glutamine, and antibiotics. Culture dishes were maintained
in a humidiﬁed 5% CO2 at 37 C.
2.3. Real-time PCR
Total RNA was extracted from cells using TRIzol reagent. One
microgram of total RNA was used as a template to make ﬁrst strand
cDNA by random priming using the Promega reverse transcriptase
system. Real-time PCR was performed using an iCycler real-time
detection system using SYBR-Green I as the ﬂuorescent dye, which en-
abled the real-time detection of PCR products according to the manu-
facturer’s instructions. The synthetic gene-speciﬁc primer sets used for
PCR were: (i) MMP-9 forward primer, 5 0-CCT ACT CTG CCT GCA
CCA CTA AA-3 0, and reverse primer, 5 0-CTG CTT GCC CAG GAA
GAC GAA-3 0, which ampliﬁed a 179-bp of mouse MMP-9 cDNA; (ii)
TNF-a forward primer, 5 0-TTC TGT CTA CTG AAC TTC GGG
GTG ATC GGT CC-30, and reverse primer, 5 0-GTA TGA GAT
AGC AAATCG GCT GAC GGT GTG GG-3 0, which ampliﬁed a
354-bp of mouse TNF-a cDNA; (iii) TNFR-I forward primer, 5 0-
CCG GGC CAC CTG GTC CG-3 0, and reverse primer, 5 0-CAA
GTA GGT TCC TTT GTG-3 0, which ampliﬁed a 306-bp of mouse
TNFR-I cDNA; (iv) TNFR-II forward primer, 5 0-GTC GCG CTG
GTC TTC GAA CTG-3 0, and reverse primer, 5 0-GGT ATA CAT
GCT TGC CTC ACA GTC-3 0, which ampliﬁed a 233-bp of mouse
TNFR-II cDNA; (v) b-actin forward primer, 5 0-TCC TTC GTT
GCC GGT CCA CA-3 0, and reverse primer, 5 0-CGT CTC CGG
AGT CCA TCA CA-3 0, which ampliﬁed a 509-bp mouse b-actin
cDNA. The PCR conditions were 94 C for 3 min, followed by 40
ampliﬁcation cycles (94 C for 30 s, 62 C for 30 s, and 72 C for
60 s). For quantiﬁcation purposes, target genes were normalized versus
b-actin.
2.4. Gelatin zymography
MMP activity was determined by gelatinase zymography using 0.1%
gelatin as a substrate in 8% SDS–polyacrylamide gel. After electropho-
resis, gels were washed three times with 2.5% Triton X-100 in water
and then incubated overnight at 37 C in 0.2% Brij 35, 5 mM CaCl2,
1 mM NaCl, and 50 mM Tris, pH 7.4, in a closed container. Gels were
then stained for 30 min with 0.25% Coomassie R-250 in 10% acetic
acid and 45% methanol and destained for 30 min using an aqueous
mixture of 20% acetic acid, 20% methanol, and 17% ethanol. Areas
of protease activity appeared as clear bands.
2.5. Western blot analysis
Cells were plated in wells (1 · 106) and treated with CpG ODN in
the presence or absence of inhibitor. They were then washed with
cold-phosphate buﬀered saline (PBS), trypsinized and pelleted at
700 · g. Cell pellets were resuspended in lysis buﬀer (50 mM Tris–
HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% Nonidet P-40,
1 mM PMSF, and protease inhibitor cocktail). The preparations were
then cleared by centrifugation and supernatants were saved as cell ly-
sates. Proteins were separated by 8% reducing SDS–PAGE and immu-
noblotted in 20% methanol, 25 mM Tris, and 192 mM glycine onto
nitrocellulose membranes. Membranes were then blocked with 5%
non-fat dry milk in TTBS (25 mM Tris–HCl, 150 mM NaCl, and
0.2% Tween 20) and incubated with primary antibody for 4 h. Subse-
quently, membranes were washed, incubated for 1 h with secondary
antibody conjugated to HRP, rewashed, and ﬁnally developed using
an enhanced ECL system.2.6. Akt phosphorylation assays
Cells were treated with CpG ODN in the presence or absence of
various inhibitors, lysed with lysis solution, and Western blotted as
described above. The membranes so obtained were probed with anti-
body against active (phosphorylated) Akt, and blots were stripped
and reproved with antibody recognizing both active and total Akt,
to demonstrate equal loading.
2.7. Detection of soluble TNF-a
Raw264.7 cells were incubated for 6 h in CpG ODN alone or in
CpG ODN containing various inhibitors. At designated time, condi-
tioned media were harvested and assayed for TNF-a in triplicate wells
by ELISA according to the manufacturer’s protocol. The data shown
represent at least three independent experiments.3. Results
3.1. CpG ODN enhanced the expressions of TNF-a and TNFR-
II, but not of TNFR-I
CpG ODN enhanced proinﬂammatory cytokine TNF-a
secretion by Raw264.7 macrophages. Because cellular activa-
tion increased TNFR expression, and high levels of TNF-a
secretion increased the expression of its receptor [12,16], we
postulated that CpG ODN would stimulate TNFR expression.
To conﬁrm that the above results were reproduced in
Raw264.7 cells, similar experiments were performed. Cells
were treated with CpG ODN for various times, and TNF-a
secretion and TNFRs expressions subsequently measured.
Like TNF-a, TNFR-II expression was increased in cell lysates
after Raw264.7 cells had been stimulated with CpG ODN
(Fig. 1A and B). In contrast, the expression of TNFR-I did
not change in response to CpG ODN (data not shown). In
addition, the mRNAs of TNF-a, TNFR-II and MMP-9 were
also increased by CpG ODN stimulation, although their kinet-
ics diﬀered (Fig. 1C). Especially, CpG ODN induced the
expression of TNF-a mRNA earlier than MMP-9 mRNA.
3.2. TLR-9 was involved in CpG ODN-induced response
RT-PCR conﬁrmed the presence of TLR-9 in Raw264.7 cells
(data not shown), which is agreement with the previous report
[17]. The antimalarial drug chloroquine has been shown to in-
hibit proinﬂammatory responses during endosomal matura-
tion [18], and recent evidence suggests that chloroquine also
inhibits TLR-9-mediated innate immune activation [19]. To
examine the eﬀect of chloroquine on CpG ODN-induced gene
expression, macrophages were stimulated with CpG ODN in
the presence of chloroquine. CpG ODN-induced TNF-a,
TNFR-II, and MMP-9 expressions were diminished by chloro-
quine (Fig. 2A). In addition, the pretreatment of macrophages
with the other endosomal acidiﬁcation inhibitor, baﬁlomycin
A [20] also completely inhibited CpG ODN-induced MMP-9
expression and the expression of TNF-a and TNFR-II
(Fig. 2B), suggesting that chloroquine or baﬁlomycin A may
inhibit CpG ODN-induced TLR-9-mediated innate immune
response.
3.3. CpG ODN-induced MMP-9 expression via the Akt pathway
Recently, a study suggested that CpG ODN induces the
phosphorylation of Akt [21]. However, the molecular mecha-
nism underlying the involvement of Akt in MMP-9 expression
has not been studied. Since Akt has been implicated in the
induction of MMP-9, we examined the eﬀect of CpG ODN
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Fig. 1. CpG ODN-induced TNF-a, TNFR-II and MMP-9 expression
but not TNFR-I. (A and B) Following overnight serum starvation,
cells were treated with 1 lM of CpG ODN for the indicated times.
Conditioned media were collected at various times and TNF-a
amounts were determined by ELISA. Whole cell lysates were used
for Western blot analysis of TNFR-II. (C) Cells were cultured with
CpG ODN (1 lM) for the indicated times and total RNA was isolated
from cells and then subjected to real-time PCR. The graph represents
fold changes of TNF-a, TNFR-I, TNFR-II, and MMP-9 mRNA after
cells were treated with CpG ODN.
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Fig. 2. TLR-9 activation mediated CpG ODN-induced MMP-9
expression. Macrophages were treated with CpG ODN (1 lM) in the
absence or presence of the indicated doses of chloroquine (A), or
baﬁlomycin A (B). Conditioned media were collected at 6 h and
analyzed for TNF-a, and portions were concentrated and analyzed
for MMP-9 expression by Zymography and Western blotting.
Whole cell lysates were used for the Western blot analysis of TNFR-
II, as indicated. Results shown are representative of two separate
experiments.
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phospho-speciﬁc antibody against Akt. When macrophages
were stimulated with 1 lM CpG ODN for diﬀerent times,
the phosphorylation level of Akt was transiently increased,
peaking after 30 min of stimulation and then decreasing at
50 min (Fig. 3A). To determine whether the activation of
Akt plays a role in the regulation of MMP-9, cells were pre-
treated with a selective inhibitor of the phosphatidylinositol
3 kinase (PI3K)-Akt pathway for 30 min and then treated with
CpG ODN for 30 min or 6 h. As shown in Fig. 3B and C, the
inhibition of Akt phosphorylation with LY294002 reduced
CpG ODN-induced MMP-9 expression, and in agreement
with this result, we found that LY294002 inhibited MMP-9
gelatinolytic activity. To conﬁrm whether the activation ofAkt plays a role in the regulation of MMP-9 expression, we
measured the mRNA level of MMP-9 in the presence of
PI3K/Akt inhibitor, and found that LY294002 strongly inhib-
its MMP-9 mRNA (Fig. 3D). In addition, the inhibition of
PI3K/Akt with LY294002 reduced CpG ODN-induced TNF-
a production and TNFR-II expression (Fig. 3E). As a control,
we tested LY294002 eﬀect in response to LPS because previous
report suggested that PI3K-Akt pathway negatively regulates
TNF-a production in response to LPS in monocytic cells
[22]. The inhibition of PI3K/Akt pathway by LY294002 did
not decrease LPS-induced TNF-a production (Fig. 3F), sug-
gesting the role of PI3K/Akt pathway diﬀerent from CpG
ODN or LPS responses.
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Fig. 3. Akt is a mediator of CpG ODN response. (A) Raw264.7 cells were treated with 1 lM CpG ODN for the indicated times. (B) Cells were
pretreated with 1 lMCpGODN in the absence or presence of LY294002. To detect Akt phosphorylation, equal amounts of cell extracts were analyzed
by Western blotting using phospho-speciﬁc Akt antibody. As a loading control, the same blots were reprobed with anti-Akt antibody. (C) Cells were
pretreated with the indicated doses of LY294002 for 1 h and stimulated with 1 lMCpG ODN. Conditioned media were collected at 6 h and analyzed
for MMP-9 expression and activity by zymography and Western blotting. (D) Cells were pretreated with 10 lM of LY294002 for 1 h and then
stimulated with 1 lM CpG ODN. Total RNA was isolated and quantitative real-time PCR was used to determine MMP-9 mRNA levels. (E and F)
Cells were pretreated with the indicated doses of LY294002 for 1 h and stimulated with 1 lM CpG ODN or 1 lg/ml LPS. Conditioned media were
collected and TNF-a levels were determined by ELISA. Whole cell lysates were used for the Western blot analysis of TNFR-II, as indicated.
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MMP-9 expression
Since our data show that CpG ODN activates Akt phos-
phorylation, we investigated the possibility of a relationship
between TLR-9 and Akt, and we found that TLR-9 inhibition
aﬀects Akt phosphorylation. Macrophages were stimulated
with CpG ODN in the absence or presence of chloroquine,
and Western blot analysis showed that CpG ODN-induced
Akt phosphorylation was blocked by pretreating chloroquine,TLR-9 inhibitor. Moreover, the phosphorylation of Akt in
cells by CpG ODN was also signiﬁcantly suppressed in the
presence of baﬁlomycin A (Fig. 4A), indicating that Akt is a
downstream kinase of TLR-9. Furthermore, our data demon-
strate that CpG ODN induces the expression of TNF-a
mRNA earlier than MMP-9 mRNA. Experiments were there-
fore performed to determine if CpG ODN exerts its eﬀects
through the production of TNF-a. To examine whether CpG
ODN-induced MMP-9 expression by macrophages is TNF-
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Fig. 4. CpG ODN-induced MMP-9 expression through the activation
of the TLR-9/Akt/TNF-a pathway. (A) Cells were pretreated with
chloroquine (10 lg/ml) or baﬁlomycin A (10 nM) for 30 min before
CpG ODN stimulation for 30 min. To detect Akt phosphorylation,
equal amounts of cell extracts were analyzed by Western blotting using
phospho-speciﬁc Akt antibody. As a loading control, the same blots
were reprobed with anti-Akt antibody. (B) Cells were pretreated with
neutralizing anti-TNF-a antibody (1 lg/ml) for 30 min before being
treated with CpG ODN (1 lM) for 6 h. Following incubation,
conditioned media were collected and analyzed for MMP expression
and activity by Western blotting and zymography.
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ing antibody. Consistent with previous results, MMP-9 was
found to be increased in the conditioned media of cells after
stimulation with CpG ODN. However, cells treated with
anti-TNF-a antibody failed to produce MMP-9 in response
to CpG ODN (Fig. 4B), which indicates that CpG ODN-in-
duced MMP-9 expression by macrophages requires TNF-a
production.4. Discussion
Previous reports have demonstrated that bacterial DNAs are
immunostimulatory and that speciﬁc nucleotide sequences
containing unmethylated CpG ODN are responsible for this
activity [2–5]. TLR-9 has been identiﬁed as a receptor of
CpG ODN. Many researches for CpG ODN have focused
upon the roles of adaptor proteins and downstream kinases
that lead to the activations of transcription factors. Although
many proteins directly or indirectly participate in innate im-mune responses, little eﬀort has been directed at understanding
the mechanism of CpG ODN-mediated MMP-9 expression.
We propose a mechanistic model of CpG ODN-induced
TLR-9 binding and Akt activation, which result in TNF-a-
mediated MMP-9 expression.
Both mitogen-activated protein kinase (MAPK) and Akt
can stimulate MMP-9 expression. Previous studies have sug-
gested a requirement for an intracellular MAPK-dependent
step for CpG ODN-mediated cellular activation [23]. More-
over, studies on macrophages have demonstrated the CpG
ODN-induced activation of various kinases [24]. Akt activa-
tion could also explain, at least in part, the role of TLR-9 in
CpG ODN-mediated MMP-9 expression. It has been reported
that CpG ODN-driven cell survival through the activation of
the PI3K-Akt pathway plays a role in regulating immune re-
sponse [25,26]. Our ﬁndings show that the expression of
MMP-9 is strongly impaired by inhibitor of the PI3K-Akt
pathway. Therefore, these results suggest that TLR-9 activa-
tion by CpG ODN regulates MMP-9 expression via a PI3K-
Akt-dependent pathway.
Previous studies have suggested a requirement for an intra-
cellular pH-dependent step in the CpG ODN-mediated activa-
tion of macrophages [20]. Especially, endosomal acidiﬁcation
is thought to be a critical step in the initiation of intracellular
CpG ODN signaling through the binding of TLR-9 [18–20,27].
Our results indicate that the expression of MMP-9 by CpG
ODN also involves this pathway. Pretreatment with baﬁlomy-
cin A (an inhibitor of vacuolar H+-ATPase) or chloroquine
(which accumulates in and increases the pH within endosomes)
strongly blocked CpG ODN-induced MMP-9 expression.
Moreover, since TLR-9 is known to be a receptor of CpG
ODN, it is believed that TLR-9 is required for the activation
of Akt by CpG ODN. Some study suggested a TLR-indepen-
dent mechanism of CpG ODN-induced cell activation [20,28].
However, the above studies suggest that TLR-9 is an impor-
tant receptor in the process leading to MMP-9 expression by
CpG ODN.
Hallmarks of chronic inﬂammation include the accumula-
tion of inﬂammatory cells and the increased degradation of
extracellular matrix (ECM) components. During tissue remod-
eling, increased ECM turnover can result in the release of de-
graded ECM components. TNF-a has been shown to be
elevated in many chronic inﬂammatory diseases. Although
TNF-a has a central role in the innate immune system for pro-
tection against infections when produced in excess, TNF-a
may also orchestrate a chronic inﬂammatory response that
leads to severe tissue damage. Previously, it was reported that
CpG ODN can induce TNF-a by macrophages [29,30]. Here,
we found that CpG ODN induces the expression of MMP-9
by macrophages. Because TNF-a can induce MMP-9, we
examined whether CpG ODN activates macrophage MMP-9
expression via TNF-a-dependent signaling. Our results show
that CpG ODN increases the expression of TNF-a prior to
MMP-9 production in macrophages, and that TNF-a signal-
ing, speciﬁcally through TNFR-II, is required for MMP-9
expression. Macrophages express surface TNFRs and respond
to TNF-a, and MMP-9 expression by macrophages does re-
quire new protein synthesis, suggesting that the CpG ODN-in-
duced expression of MMP-9 by macrophages is dependent on
TNF-a production. This hypothesis is supported by the ﬁnding
that pretreatment with neutralizing TNF-a antibody strongly
blocked basal and CpG ODN-induced MMP-9 expression.
4538 E.-J. Lim et al. / FEBS Letters 580 (2006) 4533–4538In our system, basal TNF-a amounts and MMP-9 activity
were showed in the unstimulated macrophages during cell cul-
ture. These observations suggest that basal TNF-a contributes
to basal expression of MMP-9. In addition, isotype matched
antibody with neutralizing TNF-a antibody had no eﬀect on
MMP-9 expression, excluding the possible eﬀect of non-speci-
ﬁcity of neutralizing antibody.
In this study, we examined the CpG ODN-induced mecha-
nisms in macrophages that control MMP-9, which is involved
in macrophage migration and immune response. The results
presented in this study show that CpG ODN induces TNF-a
and TNFR-II at the transcriptional level, and that these are
involved in MMP-9 expression in supernatants derived
from mouse cell line by a TLR-9 and Akt-mediated mecha-
nism.
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